Home›People›Christine Ann Tsingos
Christine Ann Tsingos

Christine Ann Tsingos

Independent board member at Araceli Biosciences Inc.

Director
Updated Nov 6, 2026·Latest SEC filing Nov 3, 2026·Suggest an edit

About Christine Ann Tsingos

Christine Tsingos is an independent board member of Araceli Biosciences Inc. She also sits on the boards of Envista Holdings, a dental products company, and Varex Imaging Corporation, which makes x-ray imaging tubes and image-processing systems for medical use. At each company she leads the audit committee and also serves on the compensation and human capital management committee.

She retired as executive vice president and chief financial officer of Bio-Rad Laboratories, a life science research and clinical diagnostics company, after holding that role from 2002 to 2019. Earlier she was assistant treasurer at The Cooper Companies, vice president and treasurer at Autodesk, and chief operating officer and chief financial officer at Attest Systems. She previously held board seats at two other public companies, Onto Innovation and Telesis Bio, where she also chaired the audit committee. In 2010 the San Francisco Business Times named her Bay Area CFO of the Year.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Christine Ann Tsingos in the role, so the role may have started earlier or lasted longer.

Araceli Biosciences Inc. Current
Independent Board Member
2026 – Present · Tigard, OR
Araceli Biosciences makes high-content imaging and AI analysis systems that help drug discovery labs screen compounds faster.
Bio-Rad Laboratories
Executive Vice President & Chief Financial Officer
2002 – 2019
The Cooper Companies
Assistant Treasurer
Autodesk
Vice President and Treasurer
Attest Systems
Chief Operating Officer & CFO

Key Colleagues at Startups

The people Christine Ann Tsingos works with at each company, as listed on that company's latest Form D.

Araceli Biosciences Inc. · Form D, Nov 3, 2026
Matt Beaudet
Matt Beaudet
President and CEO, director
WC
William Cortelyou
Chairman of the Board
Kirk Malloy
Kirk Malloy
Director
Sean O'Neill
Sean O'Neill
Director
SR
Samraat Raha
Director
Bruce Rhine
Bruce Rhine
Director

Sources

  1. SECAraceli Biosciences Inc. Form D, filed Nov 3, 2026
  2. siteAraceli Biosciences home page / board appointment press release link